An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
about
Bisphosphonate drug holiday: choosing appropriate candidatesEpidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this diseaseBisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies.Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injuryBasic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?
P2860
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
@ast
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
@en
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
@nl
type
label
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
@ast
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
@en
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
@nl
prefLabel
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
@ast
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
@en
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
@nl
P2860
P356
P1476
An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
@en
P2093
Danny McNatty
Stacy L Haber
P2860
P304
P356
10.1345/APH.1Q482
P407
P577
2012-02-14T00:00:00Z